Published in
Elsevier, EBioMedicine, (80), p. 104073, 2022
DOI: 10.1016/j.ebiom.2022.104073
Links
Tools
Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial
Journal article published in 2022 by
Zoltán Bánki 
,
Jose Mateus,
Annika Rössler,
Helena Schäfer,
David Bante,
Lydia Riepler,
Alba Grifoni,
Alessandro Sette,
Viviana Simon,
Barbara Falkensammer,
Hanno Ulmer,
Bianca Neurauter,
Wegene Borena ,
Florian Krammer,
Dorothee von Laer
and other authors.
,
Jose Mateus,
Annika Rössler,
Helena Schäfer,
David Bante,
Lydia Riepler,
Alba Grifoni,
Alessandro Sette,
Viviana Simon,
Barbara Falkensammer,
Hanno Ulmer,
Bianca Neurauter,
Wegene Borena ,
Florian Krammer,
Dorothee von Laer
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 